Original Article
Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994
N Engl J Med 1998; 339:861-867September 24, 1998
- Abstract
Background and Methods
To clarify the determinants of contemporary trends in mortality from coronary heart disease (CHD), we conducted surveillance of hospital admissions for myocardial infarction and of in-hospital and out-of-hospital deaths due to CHD among 35-to-74-year-old residents of four communities of varying size in the United States (a total of 352,481 persons in 1994). Between 1987 and 1994, we estimate that there were 11,869 hospitalizations for myocardial infarction (on the basis of 8572 hospitalizations sampled) and 3407 fatal coronary events (3023 sampled).
Results
The largest average annual decrease in mortality due to CHD occurred among white men (change in mortality, –4.7 percent; 95 percent confidence interval, –2.2 to –7.1 percent), followed by white women (–4.5 percent; 95 percent confidence interval, –0.7 to –8.2 percent), black women (–4.1 percent; 95 percent confidence interval, –10.3 to +2.5 percent), and black men (–2.5 percent; 95 percent confidence interval, –6.9 to +2.2 percent). Overall, in-hospital mortality from CHD fell by 5.1 percent per year, whereas out-of-hospital mortality declined by 3.6 percent per year. There was no evidence of a decline in the incidence of hospitalization for a first myocardial infarction among either men or women; in fact, such hospital admissions increased by 7.4 percent per year (95 percent confidence interval, 0.5 to 14.8 percent) among black women and 2.9 percent per year (95 percent confidence interval, –3.6 to +9.9 percent) among black men. Rates of recurrent myocardial infarction decreased, and survival after myocardial infarction improved.
Conclusions
From 1987 to 1994, we observed a stable or slightly increasing incidence of hospitalization for myocardial infarction. Nevertheless, there were significant annual decreases in mortality from CHD. The decline in mortality in the four communities we studied may be due largely to improvements in the treatment and secondary prevention of myocardial infarction.
Media in This Article
Figure 3
Age-Adjusted Incidence of Hospitalization for Acute Myocardial Infarction among Men and Women 35 to 74 Years Old, 1987 to 1994.Figure 2
Age-Adjusted Mortality from CHD among Men and Women 35 to 74 Years Old, 1987 to 1994, According to Whether Death Occurred in or out of the Hospital.Article Activity
- Article
Mortality from coronary heart disease (CHD) has declined steadily in the United States for the past 30 years.1,2 Between 1990 and 1994, age-adjusted mortality from CHD among people 35 years of age or older in the United States declined by 10.3 percent3; the rate of decline was highest for white men (2.9 percent per year) and lowest for black women (1.6 percent per year). National vital statistics provide mortality rates for CHD, and national hospital-discharge surveys yield rates of hospitalization for myocardial infarction. Neither measure is adequate to evaluate the incidence of CHD, however, since they are based on unvalidated codes from the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)4; thus, it may not be possible to compare rates over time and between communities.5-7
The use of accurate measures of the incidence of CHD is particularly important if the effects of primary prevention are to be distinguished from those of treatment. Much of what is known about the incidence of acute myocardial infarction and fatal CHD in the United States comes from isolated community-surveillance studies,8-11 cohort studies of cardiovascular disease,12,13 or studies of managed-care medical programs.14 Although these studies have provided valuable insights into recent trends in the occurrence of CHD, none of them alone provide annual data on the incidence of CHD in multiple large, geographically and ethnically diverse populations. Furthermore, data on incidence in the 1990s and data on out-of-hospital deaths confirmed as due to CHD are largely unavailable.
We studied population-based trends in mortality from CHD and in the incidence of myocardial infarction from 1987 to 1994. The data come from the Atherosclerosis Risk in Communities (ARIC) study, which examined the incidence of CHD in four areas of varying size, referred to in this study as communities, in the United States.15,16
Methods
Study Population
The ARIC study used a retrospective surveillance system for the continuous monitoring and analysis of hospital admissions for myocardial infarction and deaths due to CHD that occurred in or out of the hospital among all residents 35 through 74 years of age in Forsyth County, North Carolina; the city of Jackson, Mississippi; eight northern suburbs of Minneapolis; and Washington County, Maryland.
Data on Mortality Due to Chd
Death certificates that met criteria based on age, residence, and underlying cause of death (ICD-9-CM codes 250, 401, 402, 410 through 414, 427 through 429, 440, 518.4, 798, and 799) were reviewed by trained personnel, who abstracted data for the study. Few deaths among community residents occurred out of state15; such deaths were omitted. Deaths in nursing homes or emergency rooms and hospital admissions of persons classified as dead on arrival were considered to be out-of-hospital deaths. For out-of-hospital deaths, additional information was sought from the next of kin and other informants, the certifying and family physicians, and coroners or medical examiners. Because Maryland state law prohibited contacting persons listed on death certificates, we were unable to use the same method to validate causes of death for out-of-hospital deaths in Washington County. For this reason, rates of mortality due to confirmed CHD are not reported for Washington County.
Using standardized criteria,15 the ARIC Mortality and Morbidity Classification Committee reviewed out-of-hospital deaths and assigned a final diagnosis; disagreements were adjudicated by the committee chairman. In-hospital deaths were classified after a review of hospital records and death-certificate information. The rate of death due to CHD includes deaths classified as due to either a definite fatal myocardial infarction or definite CHD. This category included deaths for which no probable cause other than atherosclerosis was known in patients with a history of hospitalization for myocardial infarction within 28 days before death, as well as deaths for which there was evidence of chest pain within 72 hours before death or a history of myocardial infarction and no known nonatherosclerotic cause.
Rates of mortality due to CHD based only on the ICD-9-CM codes for the underlying cause of death are also presented in this report. A death due to unconfirmed CHD was defined by the presence of an ICD-9-CM code of 410 through 414 or 429.2 for the underlying cause of death.
Data on Hospitalization for Myocardial Infarction
Annual lists of eligible hospital discharges were obtained for each of 28 hospitals serving the four communities in the ARIC study.15 Eligibility was based on age, residence, date of discharge, and diagnosis codes (ICD-9-CM codes 402, 410 through 414, 427, 428, and 518.4). Hospitalizations of community residents outside the study area were not identified. Trained staff members recorded the following information from eligible medical records: symptoms on presentation, presence or absence of chest pain, history with respect to myocardial infarction or other cardiovascular-related conditions, and cardiac-enzyme levels on the first four days after the event. Copies of up to three electrocardiograms were made and sent to the University of Minnesota Electrocardiographic Reading Center for classification according to the Minnesota code.17 A computerized algorithm was applied to data on symptoms, cardiac enzymes, and electrocardiographic evidence to determine each patient's computer diagnosis.15 Cases with multiple hospitalizations and those with certain types of discrepancy between the discharge-diagnosis codes and the computer diagnosis were reviewed by the Mortality and Morbidity Classification Committee.
Trends in rates of hospitalization for myocardial infarction were also calculated on the basis of discharge-diagnosis codes alone. These nonvalidated events were defined by the presence of an ICD-9-CM discharge-diagnosis code of 410 (acute myocardial infarction).
Definition of a First Event
A first myocardial infarction was defined as one in a patient for whom the medical record either stated that there was no history of myocardial infarction or did not contain any reference to a history of myocardial infarction. For patients who died from cardiovascular events outside the hospital, the history was based on information obtained from the next of kin and other informants, the certifying and family physicians, the coroner or medical examiner, or the medical record for any eligible hospitalization within 28 days before death.
During the eight-year study period, 13 percent of patients hospitalized for myocardial infarction had no recorded history of myocardial infarction; this percentage was generally stable over time. The proportion of medical records in which there was no information on the history was higher for women (15 percent) and blacks (18 percent) than for men (11 percent) and whites (12 percent).
Statistical Analysis
The types of deaths and discharge diagnoses that are relatively unlikely to be confirmed as related to CHD were sampled. Sampling was based on the ICD-9-CM code and the date of discharge or death. Hospitalizations were categorized according to four mutually exclusive codes or groups of codes (ICD-9-CM codes 410; 411; 412 through 414; and 402, 427, 428, and 518.4 — with sampling probabilities of 1.0, 0.5, 0.25, and 0.1, respectively). Similarly, deaths were categorized according to two code groups (ICD-9-CM codes 410 through 414 and 429.2; and 250, 401, 402, 427, 428, 440, 518.4, 798, and 799 — with sampling probabilities of 1.0 and 0.25, respectively). Our analysis was weighted to reflect this sampling.
Rates specific for sex, race, and community were computed on the basis of dynamic population estimates derived by interpolation from U.S. Census data. Rates were adjusted for age by the direct method, according to the distribution in U.S. population in 1990. The logs of the weighted rates were modeled as linear functions of year and of age (the midpoints of five-year age groups), by Poisson regression with SAS Proc Genmod (SAS Institute, Cary, N.C.), using annual projections of the numbers of people in each group defined by five-year age group, race, and sex in the 1990 Census. Variances for the estimators of the coefficients in the model were programmed in SAS IML to account for the additional variance, beyond the Poisson variance, due to the sampling of events. Seventy-nine coronary events in persons with missing data on race or in persons who were identified as neither black nor white were excluded from these analyses.
Results
From 1987 through 1994, there were an estimated 11,869 hospital admissions (on the basis of 8572 hospitalizations sampled) for fatal or nonfatal, definite or probable acute myocardial infarctions among residents who were from 35 through 74 years old in the four communities (Table 1Table 1
Events Confirmed as Due to CHD, 1987 to 1994.). There were an estimated 3407 deaths due to CHD (3023 sampled), including both in-hospital and out-of-hospital deaths. Sixty-one percent of all coronary events occurred in persons with no recorded history of myocardial infarction (66 percent for blacks and 60 percent for whites; 65 percent for women and 59 percent for men).Trends in Mortality Due to Chd
Among men, the age-adjusted mortality from confirmed CHD fell from 3.1 per 1000 persons (95 percent confidence interval, 2.7 to 3.5) in 1987 to 2.2 per 1000 (95 percent confidence interval, 1.9 to 2.6) in 1994 (Figure 1Figure 1
Age-Adjusted Mortality from CHD among Men and Women 35 to 74 Years Old, 1987 to 1994.). The decline was observed between 1987 and 1991, with no further decline through 1994. Among women, mortality from CHD fell from 1.1 per 1000 (95 percent confidence interval, 0.9 to 1.4) in 1987 to 0.90 per 1000 (95 percent confidence interval, 0.7 to 1.1) in 1994. Mortality rates based solely on deaths for which CHD was listed as an underlying cause showed a similar pattern of change (Figure 1). Mortality from confirmed CHD among blacks showed declines similar to the overall trends. For black men, mortality fell from 3.0 per 1000 persons (95 percent confidence interval, 2.0 to 3.9) in 1987 to 2.3 per 1000 (95 percent confidence interval, 1.4 to 3.2) in 1994, and for black women, it fell from 2.4 per 1000 (95 percent confidence interval, 1.4 to 3.3) in 1987 to 1.9 per 1000 (95 percent confidence interval, 1.2 to 2.7). The annual male-to-female rate ratio for mortality from CHD was consistently greater among whites than among blacks, with overall ratios of 3.3 and 1.7, respectively.Expressed as a percentage, age-adjusted mortality from confirmed CHD declined 27.6 percent from 1987 to 1994 (95 percent confidence interval, 13.4 to 39.4 percent), an average decline of 4.0 percent per year, for men, and 31.3 percent (95 percent confidence interval, 8.8 to 48.3 percent), or 4.6 percent per year, for women (Table 2Table 2
Average Annual Change in Mortality Due to Confirmed CHD and Case Fatality Rates, Adjusted for Age, 1987 to 1994.). The average declines among white men and white women were similar and statistically significant. The average declines of 2.5 percent per year for black men and 4.1 percent per year for black women were not significantly different from no decline.Among men, 64 percent of all deaths due to CHD occurred outside the hospital, with essentially no change in this percentage between 1987 and 1994. About half of all deaths due to CHD among women during this period were out-of-hospital deaths, except in 1988 and 1994, when this proportion was about a third. The percentage of deaths due to CHD that occurred outside the hospital among blacks was as high as 74 percent and was generally higher than among whites.
Both out-of-hospital and in-hospital mortality due to CHD declined (Figure 2Figure 2
Age-Adjusted Mortality from CHD among Men and Women 35 to 74 Years Old, 1987 to 1994, According to Whether Death Occurred in or out of the Hospital.). Overall, in-hospital mortality from CHD fell by 5.1 percent per year (95 percent confidence interval, 2.1 to 8.1 percent), whereas out-of-hospital mortality declined by 3.6 percent per year (95 percent confidence interval, 1.3 to 5.8 percent). For men, the decline in the rate of in-hospital death from CHD was 5.1 percent (95 percent confidence interval, 1.5 to 8.5 percent) per year, and the decline in the rate of out-of-hospital death was 3.4 percent (95 percent confidence interval, 0.7 to 6.0 percent) per year. Trends among women were similar. Declines in mortality from CHD were also similar for persons less than 55 years of age and for those 55 or older.Trends in the Incidence of Hospitalization for Myocardial Infarction
The age-adjusted incidence of hospitalization for myocardial infarction changed little over the eight-year period (Figure 3Figure 3
Age-Adjusted Incidence of Hospitalization for Acute Myocardial Infarction among Men and Women 35 to 74 Years Old, 1987 to 1994.). The rate of such hospitalization among women was 1.9 per 1000 persons (95 percent confidence interval, 1.6 to 2.2) in 1987 and 1.8 per 1000 (95 percent confidence interval, 1.5 to 2.1) in 1994. For men, the rate was the same in 1994 as in 1987 — 4.1 hospitalizations per 1000. The annual male-to-female rate ratio for hospitalization for myocardial infarction was consistently higher among whites than among blacks, with overall ratios of 2.5 and 1.4, respectively.Expressed as a percentage, the age-adjusted rate of hospitalization for myocardial infarction from 1987 to 1994 increased by 1.1 percent (95 percent confidence interval, –13.1 to +17.5 percent), an average increase of 0.1 percent per year, for men, and declined by 1.7 percent (95 percent confidence interval, 20.8 to –22.0 percent [the negative number indicates an increase]), an average decline of 0.2 percent per year, for women (Table 2). When the average annual percent change in incidence was calculated on the basis of nonvalidated events, the changes were close to zero both for men (an increase of 1.0 percent [95 percent confidence interval, –0.2 to +2.3 percent]) and for women (an increase of 0.6 percent [95 percent confidence interval, –1.2 to +2.4]).
Although the incidence of hospitalization for myocardial infarction was more variable among blacks, there was evidence of an increase in this rate. The age-adjusted annual incidence increased by 2.9 percent per year among black men and by 7.4 percent per year among black women (the increase among women was statistically significant). The incidence declined an average of 2.5 percent per year among white women, whereas there was essentially no change in the annual rate among white men (a decrease of 0.3 percent per year). In addition, the incidence among men 55 to 74 years of age increased significantly, by 4.6 percent per year (95 percent confidence interval, 2.1 to 7.2), whereas other age-specific rates for men 35 through 54 years of age and for women did not change significantly.
The rate of a combined end point defined as the incidence of acute myocardial infarction or fatal CHD in patients (without a history of myocardial infarction) changed little between 1987 and 1994 (Table 2), declining by only 1.1 percent annually for men and increasing by only 0.4 percent per year for women (P not significant for both comparisons).
Trends in Recurrent Myocardial Infarction
In contrast to the flat trends in the rates of hospitalization for myocardial infarction, the annual rates of recurrent myocardial infarction showed a significant 18.8 percent decline among men (2.6 percent per year) and a nonsignificant 14.5 percent decline among women (1.9 percent per year) (Table 2).
Trends in the Case Fatality Rate at 28 Days
The 28-day case fatality rate among patients with definite or probable myocardial infarction who were hospitalized in the period from 1987 through 1994, with adjustment for year and age, was 10.6 percent (95 percent confidence interval, 8.7 to 13.0 percent) for women and 9.0 percent (95 percent confidence interval, 7.8 to 10.4 percent) for men. Overall, the decrease in the age-adjusted case fatality rate was 4.1 percent per year for men and 9.8 percent per year for women. This decline was statistically significant only among women, primarily because of the relatively large decline among white women (Table 2). There was no evidence of a decline in the case fatality rate among blacks hospitalized for myocardial infarction.
An estimate of the overall case fatality rate from CHD combines information on mortality at 28 days among patients hospitalized for myocardial infarction with information on deaths attributed to CHD that did not occur in conjunction with an event for which the patient was hospitalized. The overall case fatality rate declined among both men (by 3.9 percent per year) and women (by 6.1 percent per year). This decline was significant for whites but not for blacks.
Discussion
We found that mortality due to CHD declined among 35-to-74-year-old residents of four geographically and ethnically diverse communities in the United States from 1987 to 1994; the decline was 28 percent for men and 31 percent for women. The decline was evident among both blacks and whites. Among men, most of the decline was observed between 1987 and 1991, with stable rates through 1994. The decrease in mortality due to CHD was accompanied by declining case fatality rates and declining rates of hospitalization for recurrent myocardial infarction. In contrast, the incidence of hospitalization for myocardial infarction was stable or increased slightly. These findings suggest that the decrease in mortality due to CHD between 1987 and 1994 in these communities may be due largely to improvements in the treatment of myocardial infarction and to secondary prevention (rather than to a decline in new events). The rates of both in-hospital and out-of-hospital death due to CHD declined; therefore, the percentage of deaths due to CHD that occurred outside the hospital changed little between 1987 and 1994. Future efforts to reduce the burden of mortality from CHD in the community must address the prevention of out-of-hospital deaths — a goal that may require better primary prevention as well as more timely access to medical care.
The downward trend in mortality from CHD was consistent with that reported from analyses of U.S. vital statistics.3 The overall decline in age-adjusted mortality from CHD in the study communities in the late 1980s and the early 1990s does not bear out the prediction, based on simulation studies, that the increase in the prevalence of CHD in the pool of patients at risk between 1980 and 1990 would cause age-adjusted mortality from CHD to rise in the 1990s.18 We did not, however, determine mortality from CHD for persons over 74 years of age, a group in which the prevalence could be increasing because the population is living longer.
The significant improvement in survival after hospitalization for myocardial infarction (an increase of 28 to 56 percent) suggests an important contribution of medical care to recent trends in mortality from CHD. Similarly, the Minnesota Heart Survey reported that the risk of death within the 28 days after a myocardial infarction was 15 to 25 percent lower in 1990 than in 1985.9
Although the declines in mortality due to CHD and in case fatality rates are encouraging, the lack of change — or, for black women, the increase — in the incidence of acute myocardial infarction raises several issues. First, this trend represents a departure from previous reports: between 1985 and 1990, the incidence of myocardial infarction declined by approximately 1 percent annually in Minneapolis9; between 1975 and 1988, the incidence fell by 2 percent per year in Worcester, Massachusetts8; and between 1965 and 1979, the incidence declined by 1.4 percent per year in Rochester, Minnesota.19 Although the Corpus Christi Heart Project did not report the percent change in incidence, this group concluded that there were nonsignificant declines in incidence among Mexican Americans and no appreciable change among non-Hispanic whites from 1989 to 1991.20 Second, the difference in trends between blacks and whites suggests that current efforts to prevent CHD may be reaching blacks less effectively than whites. Further research is needed to confirm that the increase in the incidence of myocardial infarction among blacks is real and also to identify public health strategies that address this discrepancy.
The conclusion that medical care and secondary prevention have the most important roles in the observed trends in mortality from CHD is supported by the absence of a decline in the incidence of CHD and by improvements in the case fatality rate. These findings are consistent with the results of computer-simulation modeling, which suggested that 25 percent of the decline in CHD in the 1980s was attributable to primary prevention and more than 70 percent to the effects of reductions in risk factors or improvements in the treatment of patients with CHD.18 Other simulation-based estimates suggest that primary prevention accounted for a greater proportion of the decline in CHD in the late 1960s and 1970s.21-23 Although the incidence of myocardial infarction did not change in the communities in the ARIC study, primary prevention may have affected the severity of myocardial infarction and thereby lowered the case fatality rate. However, preliminary analysis of trends in the severity of myocardial infarction in the study (indicated by hemodynamic, cardiac-enzyme, and electrocardiographic variables) suggests no decline (unpublished data).
Continued community surveillance of trends in CHD is needed to evaluate the effects of new preventive and treatment measures such as the use of statin drugs to lower cholesterol,24 since their use was not widespread in 1994. National vital statistics alone will not be adequate to evaluate the relative effect of these and other emerging efforts in prevention and treatment. Further evaluation of the reasons for the change in mortality due to CHD in the study communities awaits additional analyses of trends in the severity of disease and detailed investigations of changes in risk factors.
Supported by contracts (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) with the National Heart, Lung, and Blood Institute.
Source Information
From the Departments of Epidemiology (W.D.R., G.H.) and Biostatistics (L.E.C., L.C., C.-H.W.), School of Public Health, University of North Carolina, Chapel Hill; the Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (A.R.F.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (L.S.C.); and the Division of Epidemiology, Department of Preventive Medicine, University of Mississippi Medical Center, Jackson (D.E.C.).
Address reprint requests to Dr. Rosamond at the Department of Epidemiology, University of North Carolina at Chapel Hill, CB 7400, McGavran-Greenberg Hall, Chapel Hill, NC 27599.
Appendix
In addition to the authors, the following also participated in this study: University of North Carolina, Chapel Hill — P. Johnson, M. Knowles, C. Paton; Wake Forest University, Winston-Salem, N.C. — K. Burke, W. Cheeks, R. Cook, S. Cothern; University of Mississippi Medical Center, Jackson — B. Warren, D. Washington, M. Watson, N. Wilson; University of Minnesota, Minneapolis — G. Feitl, C. Hunkins, E. Justiniano, L. Kemmis; Johns Hopkins University, Baltimore — J. Chabot, C. Christman, D. Costa, P. Crowley; University of Texas Medical School, Houston — V. Stinson, P. Pfile, H. Pham, T. Trevino; Atherosclerosis Clinical Laboratory, Methodist Hospital, Houston — W. Alexander, D. Harper, C. Rhodes, S. Soyal; Ultrasound Reading Center, Bowman Gray School of Medicine, Winston-Salem, N.C. — A. Safrit, M. Wilder, L. Allred, C. Bell; Coordinating Center, University of North Carolina, Chapel Hill — P. DeSaix, S. Goode, T. Goodwin, S. Hutton.
- References
References
1
Higgins MW, Luepker RV. Trends in coronary heart disease mortality: the influence of medical care. New York: Oxford University Press, 1988:301.
2
Gillum R . Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1994;23:1273-1277
CrossRef | Web of Science | Medline3
Trends in ischemic heart disease deaths -- United States, 1990-1994
Medline4
Department of Health and Human Services. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. Vol. 1. Diseases: tabular list. Washington, D.C.: Government Printing Office, 1980. (DHHS publication no. (PHS) 80-1260.)
5
Burke GL ,Edlavitch SA ,Crow RS . The effect of diagnostic criteria on trends in coronary heart disease morbidity: the Minnesota Heart Survey. J Clin Epidemiol 1989;42:17-24
CrossRef | Web of Science | Medline6
Assaf AR ,Lapane KL ,McKenney JL ,Carleton RA . Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med 1993;329:931-935
Full Text | Web of Science | Medline7
Pankow JS ,McGovern PG ,Sprafka JM ,Jacobs DR Jr ,Blackburn H . Trends in coded causes of death following definite myocardial infarction and the role of competing risks: the Minnesota Heart Survey (MHS). J Clin Epidemiol 1994;47:1051-1060
CrossRef | Web of Science | Medline8
Goldberg RJ ,Gorak EJ ,Yarzebski J , et al. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-1953
Web of Science | Medline9
McGovern PG ,Pankow JS ,Shahar E , et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-890
Full Text | Web of Science | Medline10
Nichaman MZ ,Wear ML ,Goff DC Jr ,Labarthe DR . Hospitalization rates for myocardial infarction among Mexican-Americans and non-Hispanic whites: the Corpus Christi Heart Project. Ann Epidemiol 1993;3:42-48
CrossRef | Medline11
Fortmann SP ,Haskell WL ,Williams PT ,Varady AN ,Hulley SB ,Farquhar JW . Community surveillance of cardiovascular diseases in the Stanford Five-City Project: methods and initial experience. Am J Epidemiol 1986;123:656-669
Web of Science | Medline12
Ives DG ,Fitzpatrick AL ,Bild DE , et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol 1995;5:278-285
CrossRef | Medline13
Sytkowski PA ,D'Agostino RB ,Belanger A ,Kannel WB . Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996;143:338-350
Web of Science | Medline14
Sidney S ,Karter AJ ,Fireman BH ,Sadler MC ,Friedman GD . Trends in cardiovascular disease mortality and hospitalization incidence rates in the Kaiser Permanente Medical Care Program, 1978-1993. Circulation 1996;93:Suppl I:I-2 abstract.15
White AD ,Folsom AR ,Chambless LE , et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-233
CrossRef | Web of Science | Medline16
The ARIC Investigators
Web of Science | Medline17
Edlavitch SA ,Crow R ,Burke GL ,Huber J ,Prineas R ,Blackburn H . The effect of the number of electrocardiograms analyzed on cardiovascular disease surveillance: the Minnesota Heart Study (MHS). J Clin Epidemiol 1990;43:93-99
CrossRef | Web of Science | Medline18
Hunink MG ,Goldman L ,Tosteson AN , et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997;277:535-542
CrossRef | Web of Science | Medline19
Elveback LR ,Connolly DC ,Melton LJ III . Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 1986;61:896-900
Web of Science | Medline20
Goff DC ,Nichaman MZ ,Chan W ,Ramsey DJ ,Labarthe DR ,Ortiz C . Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites: the Corpus Christi Heart Project, 1988-1992. Circulation 1997;95:1433-1440
Web of Science | Medline21
Goldman L ,Cook EF . The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984;101:825-836
Web of Science | Medline22
Cohn BA ,Kaplan GA ,Cohen RD . Did early detection and treatment contribute to the decline in ischemic heart disease mortality? Prospective evidence from the Alameda County Study. Am J Epidemiol 1988;127:1143-1154
Web of Science | Medline23
Kaplan GA ,Cohn BA ,Cohen RD ,Guralnik J . The decline in ischemic heart disease mortality: prospective evidence from the Alameda County Study. Am J Epidemiol 1988;127:1131-1142
Web of Science | Medline24
Scandinavian Simvastatin Survival Study Group
Web of Science | Medline
- Citing Articles (228)
Citing Articles
1
Vikas Veeranna, Sandip K. Zalawadiya, Ashutosh Niraj, Abhimanyu Kumar, Brian Ference, Luis Afonso. (2012) Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: Results from a multi-ethnic cohort. International Journal of Cardiology
CrossRef2
Min Li, Gang Sun, Juan Ding, Li Li, Zhao-hui Peng, Xiang-sen Jiang. (2012) Risk Factors for Non-calcified Plaques in Asymptomatic Population. Academic Radiology
CrossRef3
Nicholas B. Norgard, Mazen S. Abu-Fadel. 2011. Cardiovascular Disease: In-Depth Look. .
CrossRef4
Lisa Ericson, Lennart Bergfeldt, Ingela Björholt. (2011) Atrial fibrillation: the cost of illness in Sweden. The European Journal of Health Economics 12:5, 479-487
CrossRef5
R. Margey, L. Browne, E. Murphy, M. O'Reilly, N. Mahon, G. Blake, H. McCann, D. Sugrue, J. Galvin. (2011) The Dublin cardiac arrest registry: temporal improvement in survival from out-of-hospital cardiac arrest reflects improved pre-hospital emergency care. Europace 13:8, 1157-1165
CrossRef6
Randi E. Foraker, Kathryn M. Rose, Anna M. Kucharska-Newton, Hanyu Ni, Chirayath M. Suchindran, Eric A. Whitsel. (2011) Variation in Rates of Fatal Coronary Heart Disease by Neighborhood Socioeconomic Status: The Atherosclerosis Risk in Communities Surveillance (1992–2002). Annals of Epidemiology 21:8, 580-588
CrossRef7
C. Deasy, J.E. Bray, K. Smith, R. Wolfe, L.R. Harriss, S.A. Bernard, P. Cameron. (2011) Cardiac arrest outcomes before and after the 2005 resuscitation guidelines implementation: Evidence of improvement?. Resuscitation 82:8, 984-988
CrossRef8
Christi Deaton, Erika Sivarajan Froelicher, Lai Har Wu, Camille Ho, Kawkab Shishani, Tiny Jaarsma. (2011) The global burden of cardiovascular disease. European Journal of Cardiovascular Nursing 10, S5-S13
CrossRef9
J. Vanderlelie, A.V.A. Perkins. (2011) Selenium and preeclampsia: A global perspective. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:3-4, 213-224
CrossRef10
Z.-J. Yang, J. Liu, J.-P. Ge, L. Chen, Z.-G. Zhao, W.-Y. Yang, . (2011) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. European Heart Journal
CrossRef11
Isabel Rey Madeira, Maria Alice Neves Bordallo, Cecilia Noronha Miranda Carvalho, Fernanda Mussi Gazolla, Flavio Moutinho de Souza, Haroldo José de Matos, Marcos Antônio Borges. (2011) The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children. Journal of Pediatric Endocrinology and Metabolism 24:5-6, 289-295
CrossRef12
Jenny S. Choy, Mark Svendsen, Xiao Lu, Hai Zheng, Matthew S. Sulkin, Anjan K. Sinha, Celina Morales, Issam Moussa, José A. Navia, Ghassan S. Kassab. (2011) Selective autoretroperfusion preserves myocardial function during coronary artery ligation in swine. Acute Cardiac Care 13:2, 99-108
CrossRef13
Daniel J. Crespin, Jerome J. Federspiel, Andrea K. Biddle, Daniel E. Jonas, Joseph S. Rossi. (2011) Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome: A Cost-Effectiveness Analysis. Value in Health 14:4, 483-491
CrossRef14
Jean-Louis Vincent, David R. Nelson, Mark D. Williams. (2011) Is worsening multiple organ failure the cause of death in patients with severe sepsis?*. Critical Care Medicine 39:5, 1050-1055
CrossRef15
C. Blomstrom Lundqvist, G. Y. H. Lip, P. Kirchhof. (2011) What are the costs of atrial fibrillation?. Europace 13:Supplement 2, ii9-ii12
CrossRef16
M.K. Kathiravan, Nikhil Vidyasagar, Rahul Khiste, Aparna Chote, Kishor Jain. (2011) Synthesis and antihyperlipidemic activity of some novel 4-substituted-2-substitutedmethyltriazino[6,1-b]quinazolin-10-ones and 2,4-disubstituted-6,7-dimethoxy quinazoline. Arabian Journal of Chemistry
CrossRef17
Russell V. Luepker. (2011) Cardiovascular Disease: Rise, Fall, and Future Prospects. Annual Review of Public Health 32:1, 1-3
CrossRef18
P. Pierucci, G. Misciagna, M.T. Ventura, R. Inguaggiato, A.M. Cisternino, V.M.B. Guerra, P. Suppressa, F. Resta, C. Sabbà. (2011) Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy. Nutrition, Metabolism and Cardiovascular Diseases
CrossRef19
Jianhui Wu, Ming Zhao, Shiqi Peng. (2011) Quinazolin-4(3H)-ones capable of upregulating the expression of endogenous apolipoprotein A-1. Expert Opinion on Therapeutic Patents 21:3, 431-435
CrossRef20
Christian T. Ruff, Eugene Braunwald. (2011) The evolving epidemiology of acute coronary syndromes. Nature Reviews Cardiology 8:3, 140-147
CrossRef21
Bekir Erol, Musturay Karcaaltincaba, Nurdan Cay, Tuncay Hazirolan, Kudret Aytemir, Deniz Akata. (2011) Effectiveness Best R-R Reconstruction Interval Determination Software for the Evaluation of Dual-Source Coronary CT Angiography Examinations. Journal of Computer Assisted Tomography 35:2, 229-234
CrossRef22
Rajendra H. Mehta, J. Conor O'Shea, Amanda L. Stebbins, Christopher B. Granger, Paul W. Armstrong, Harvey D. White, Eric J. Topol, Robert M. Califf, E. Magnus Ohman. (2011) Association of Mortality With Years of Education in Patients With ST-Segment Elevation Myocardial Infarction Treated With Fibrinolysis. Journal of the American College of Cardiology 57:2, 138-146
CrossRef23
Najwa Ouhoummane, Belkacem Abdous, Rabia Louchini, Louis Rochette, Paul Poirier. (2010) Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001. Canadian Journal of Cardiology 26:10, 523-531
CrossRef24
Earl S. Ford, Chaoyang Li, Guixiang Zhao, William S. Pearson, James Tsai, Kurt J. Greenlund. (2010) Trends in low-risk lifestyle factors among adults in the United States: Findings from the Behavioral Risk Factor Surveillance System 1996–2007. Preventive Medicine 51:5, 403-407
CrossRef25
Kevin L. Thomas, Emily Honeycutt, Linda K. Shaw, Eric D. Peterson. (2010) Racial differences in long-term survival among patients with coronary artery disease. American Heart Journal 160:4, 744-751
CrossRef26
Kumiko Hamano, Mariko Abe, Rieko Komi, Shuzo Kobayashi. (2010) N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria. Diabetes/Metabolism Research and Reviews 26:7, 534-539
CrossRef27
Nina P. Paynter, A. Richey Sharrett, Thomas A. Louis, Wayne Rosamond, Aaron R. Folsom, Josef Coresh. (2010) Paired Comparison of Observed and Expected Coronary Heart Disease Rates over 12 Years from the Atherosclerosis Risk In Communities Study. Annals of Epidemiology 20:9, 683-690
CrossRef28
Kimbach T. Carpiuc, Deborah L. Wingard, Donna Kritz-Silverstein, Elizabeth Barrett-Connor. (2010) The Association of Angina Pectoris with Heart Disease Mortality Among Men and Women by Diabetes Status: The Rancho Bernardo Study. Journal of Women's Health 19:8, 1433-1439
CrossRef29
Shile B. Dayton, Dale P. Sandler, Aaron Blair, Michael Alavanja, Laura E. Beane Freeman, Jane A. Hoppin. (2010) Pesticide Use and Myocardial Infarction Incidence Among Farm Women in the Agricultural Health Study. Journal of Occupational and Environmental Medicine 52:7, 693-697
CrossRef30
Nailet Arráiz, Valmore Bermúdez, Carem Prieto, Maria Patricia Sánchez, Carolina Escalona, Eileen Sanz, Netxibeth Rondón, Francia Reyes, Manuel Velasco. (2010) Association Between Apoliprotein E Gene Polymorphism and Hypercholesterolemic Phenotype in Maracaibo, Zulia State, Venezuela. American Journal of Therapeutics 17:3, 330-336
CrossRef31
Alfredo Morabia. (2010) Preventive Medicine 50:4, 217-219
CrossRef32
M. Schmutz, S. Beer-Borst, A. Meiltz, P. Urban, J. M. Gaspoz, M. C. Costanza, A. Morabia, M. Zimmermann. (2010) Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland. Europace 12:4, 475-481
CrossRef33
Dennis T. Ko, Alice M. Newman, David A. Alter, Peter C. Austin, Maria Chiu, Jafna L. Cox, Shaun G. Goodman, Jack V. Tu. (2010) Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. Canadian Journal of Cardiology 26:3, 129-134
CrossRef34
Chizobam Ani, Deyu Pan, David Martins, Bruce Ovbiagele. (2010) Age- and Sex-Specific In-Hospital Mortality after Myocardial Infarction in Routine Clinical Practice. Cardiology Research and Practice 2010, 1-11
CrossRef35
Eun Ju Ha, Yookyung Kim, Joo Yeon Cheung, Sung Shine Shim. (2010) Coronary Artery Disease in Asymptomatic Young Adults: Its Prevalence According to Coronary Artery Disease Risk Stratification and the CT Characteristics. Korean Journal of Radiology 11:4, 425
CrossRef36
Limin X. Clegg, Benjamin F. Hankey, Ram Tiwari, Eric J. Feuer, Brenda K. Edwards. (2009) Estimating average annual per cent change in trend analysis. Statistics in Medicine 28:29, 3670-3682
CrossRef37
Eric Y. Yang, Vijay Nambi, Zhengzheng Tang, Salim S. Virani, Eric Boerwinkle, Ron C. Hoogeveen, Brad C. Astor, Thomas H. Mosley, Josef Coresh, Lloyd Chambless, Christie M. Ballantyne. (2009) Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population. Journal of the American College of Cardiology 54:25, 2388-2395
CrossRef38
Kathryn M. Rose, Chirayath M. Suchindran, Randi E. Foraker, Eric A. Whitsel, Wayne D. Rosamond, Gerardo Heiss, Joy L. Wood. (2009) Neighborhood Disparities in Incident Hospitalized Myocardial Infarction in Four U.S. Communities: The ARIC Surveillance Study. Annals of Epidemiology 19:12, 867-874
CrossRef39
Bernhard C. Danner, Vassilios N. Didilis, Tomislav Stojanovic, Aron Popov, Marius Grossmann, Ralf Seipelt, Friedrich A. Schöndube. (2009) A Three-Group Model to Predict Mortality in Emergent Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 88:5, 1433-1439
CrossRef40
J. R. Rashid, R. F. Spengler, R. M. Wagner, C. Melanson, E. L. Skillen, R. A. Mays, S. Heurtin-Roberts, J. A. Long. (2009) Eliminating Health Disparities Through Transdisciplinary Research, Cross-Agency Collaboration, and Public Participation. American Journal of Public Health 99:11, 1955-1961
CrossRef41
Vincenzo Nuzzo, Anna Maria de Milita, Teresa Ferraro, Antonio Monaco, Enrico Florio, Pasquale Miano, Emilio Montemarano, Alfonso Zuccoli, Francesca de Terlizzi. (2009) Analysis of Skeletal Status by Quantitative Ultrasonometry in a Cohort of Postmenopausal Women with High Blood Cholesterol Without Documented Osteoporosis. Ultrasound in Medicine & Biology 35:5, 717-722
CrossRef42
A. Martling, F. Granath, B. Cedermark, R. Johansson, T. Holm. (2009) Gender differences in the treatment of rectal cancer: A population based study. European Journal of Surgical Oncology (EJSO) 35:4, 427-433
CrossRef43
David Ly, Fu Z. Alex, Hebert Christopher. (2009) Cost Effectiveness Analysis of a Hypertension Management Program in Patients With Type 2 Diabetes. The Journal of Clinical Hypertension 11:3, 116-124
CrossRef44
Brad E. Zacharia, Zachary L. Hickman, Bartosz T. Grobelny, Peter A. DeRosa, Andrew F. Ducruet, E. Sander Connolly. (2009) Complement Inhibition as a Proposed Neuroprotective Strategy following Cardiac Arrest. Mediators of Inflammation 2009, 1-7
CrossRef45
K. Berneis, M. Rizzo, M. Hersberger, G. B. Rini, G. Di Fede, I. Pepe, G. A Spinas, E. Carmina. (2009) Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice 63:1, 56-62
CrossRef46
Jonathan Newman, William A. Grobman, Philip Greenland. (2008) Combination Polypharmacy for Cardiovascular Disease Prevention in Men: A Decision Analysis and Cost-Effectiveness Model. Preventive Cardiology 11:1, 36-41
CrossRef47
Blanca Novella, Margarita Alonso, Francisco Rodriguez-Salvanés, Rosario Susi, Blanca Reviriego, Luisa Escalante, Carmen Suárez, Rafael Gabriel. (2008) Incidencia a diez años de infarto de miocardio fatal y no fatal en la población anciana de Madrid. Revista Española de Cardiología 61:11, 1140-1149
CrossRef48
Ming-Chia Hsieh, Kai-Jen Tien, Shun-Jen Chang, Daw-Shyong Perng, Jeng-Yueh Hsiao, Yu-Wen Chen, Yu-Hung Chang, Hsuan-Wen Kuo, Pi-Chen Lin. (2008) High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus. Metabolism 57:11, 1533-1538
CrossRef49
Geir Arild Espnes, Don Byrne. (2008) Gender differences in psychological risk factors for development of heart disease. Stress and Health 24:3, 188-195
CrossRef50
Alexandra Schneider, Angela Schuh, Friedrich-Karl Maetzel, Regina Rückerl, Susanne Breitner, Annette Peters. (2008) Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women. International Journal of Biometeorology 52:6, 535-547
CrossRef51
Nena Aleksic, Yao-Wei W. Wang, Chul Ahn, Harinder S. Juneja, Aaron R. Folsom, Kenneth K. Wu. (2008) Assessment of coronary heart disease risk by combined analysis of coagulation factors. Atherosclerosis 198:2, 294-300
CrossRef52
F. M. Sanfilippo, M. S. T. Hobbs, M. W. Knuiman, J. Hung. (2008) Impact of New Biomarkers of Myocardial Damage on Trends in Myocardial Infarction Hospital Admission Rates from Population-based Administrative Data. American Journal of Epidemiology 168:2, 225-233
CrossRef53
Roman Fleischhackl, Bernhard Roessler, Hans Domanovits, Florian Singer, Sabine Fleischhackl, Gerald Foitik, Gerald Czech, Martina Mittlboeck, Reinhard Malzer, Philip Eisenburger, Klaus Hoerauf. (2008) Results from Austria's nationwide public access defibrillation (ANPAD) programme collected over 2 years. Resuscitation 77:2, 195-200
CrossRef54
Gabrielle Velde, Sheilah Hogg-Johnson, Ahmed M. Bayoumi, J. David Cassidy, Pierre Côté, Eleanor Boyle, Hilary Llewellyn-Thomas, Stella Chan, Peter Subrata, Jan Lucas Hoving, Eric Hurwitz, Claire Bombardier, Murray Krahn. (2008) Identifying the Best Treatment Among Common Nonsurgical Neck Pain Treatments. European Spine Journal 17:S1, 184-191
CrossRef55
Soko Setoguchi, Robert J. Glynn, Jerry Avorn, Murray A. Mittleman, Raisa Levin, Wolfgang C. Winkelmayer. (2008) Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge. Journal of the American College of Cardiology 51:13, 1247-1254
CrossRef56
William E. Boden, David J. Maron. (2008) Reducing Post-Myocardial Infarction Mortality in the Elderly. Journal of the American College of Cardiology 51:13, 1255-1257
CrossRef57
Bill Lands. (2008) A critique of paradoxes in current advice on dietary lipids. Progress in Lipid Research 47:2, 77-106
CrossRef58
Gabrielle van der Velde, Sheilah Hogg-Johnson, Ahmed M. Bayoumi, J David Cassidy, Pierre Côté, Eleanor Boyle, Hilary Llewellyn-Thomas, Stella Chan, Peter Subrata, Jan Lucas Hoving, Eric Hurwitz, Claire Bombardier, Murray Krahn. (2008) Identifying the Best Treatment Among Common Nonsurgical Neck Pain Treatments. Spine 33:Neck Pain Suppl, S184-S191
CrossRef59
Wolfgang C. Winkelmayer, Anna E. Bucsics, Alexandra Schautzer, Peter Wieninger, Michaela Pogantsch, . (2008) Use of recommended medications after myocardial infarction in Austria. European Journal of Epidemiology 23:2, 153-162
CrossRef60
Arif Mutwali, Liam G Glynn, Donal Reddan. (2008) Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease. American Journal of Cardiovascular Drugs 8:4, 219-231
CrossRef61
Walter C. Willett. (2008) Will High-Carbohydrate/Low-Fat Diets Reduce the Risk of Coronary Heart Disease?. Proceedings of the Society for Experimental Biology and Medicine 225:3, 187
CrossRef62
Manfredi Rizzo, Kaspar Berneis, Enrico Carmina, Giovam Battista Rini. (2008) How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?. American Journal of Obstetrics and Gynecology 198:1, 28.e1-28.e5
CrossRef63
Michael P. Hutchens, Takaaki Nakano, Jennifer Dunlap, Richard J. Traystman, Patricia D. Hurn, Nabil J. Alkayed. (2008) Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation. Resuscitation 76:1, 89-94
CrossRef64
Earl S. Ford, Simon Capewell. (2007) Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002. Journal of the American College of Cardiology 50:22, 2128-2132
CrossRef65
Gil N. Bachar, Eli Atar, Shmuell Fuchs, Dicker Dror, Ran Kornowski. (2007) Prevalence and clinical predictors of atherosclerotic coronary artery disease in asymptomatic patients undergoing coronary multidetector computed tomography. Coronary Artery Disease 18:5, 353-360
CrossRef66
Y. Hong, X. Jin, J. Mo, H.-M. Lin, Y. Duan, M. Pu, D. L. Wolbrette, D. Liao. (2007) Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality ? results of prospective analysis for the Atherosclerosis Risk in Communities study. Journal of Internal Medicine 262:1, 113-122
CrossRef67
Wissam A. Jaber, David R. Holmes. (2007) Outcome and Quality of Care of Patients who have Acute Myocardial Infarction. Medical Clinics of North America 91:4, 751-768
CrossRef68
Kishor S. Jain, M.K. Kathiravan, Rahul S. Somani, Chamanlal J. Shishoo. (2007) The biology and chemistry of hyperlipidemia. Bioorganic & Medicinal Chemistry 15:14, 4674-4699
CrossRef69
Véronique L. Roger. (2007) Epidemiology of Myocardial Infarction. Medical Clinics of North America 91:4, 537-552
CrossRef70
Troy Labounty, Kim A. Eagle. (2007) The nature of the problem: an overview of acute coronary syndromes and myocardial infarction. Biological Rhythm Research 38:3, 143-153
CrossRef71
David T. Miller, Paul M. Ridker, Peter Libby, David J. Kwiatkowski. (2007) Atherosclerosis. Journal of the American College of Cardiology 49:15, 1589-1599
CrossRef72
E Marijon, L Trinquart, D Jani, H Jourdier, E Garbarz, A O Mocumbi, D S Celermajer, B Ferreira. (2007) Coronary heart disease and associated risk factors in sub-Saharan Africans. Journal of Human Hypertension
CrossRef73
Prakash C Deedwania, Dean G Smith. (2007) Clinical efficacy and cost–effectiveness of rosuvastatin. Expert Review of Pharmacoeconomics & Outcomes Research 7:1, 31-39
CrossRef74
Sauyu Lin, Richard Konstance, James Jollis, Deborah A. Fisher. (2006) The Utility of Upper Endoscopy in Patients with Concomitant Upper Gastrointestinal Bleeding and Acute Myocardial Infarction. Digestive Diseases and Sciences 51:12, 2377-2383
CrossRef75
2006. Post-Myocardial Infarction. .
CrossRef76
Anirban Basu, Bhakti V. Arondekar, Paul J. Rathouz. (2006) Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity. Health Economics 15:10, 1091-1107
CrossRef77
Umed A. Ajani, Earl S. Ford. (2006) Has the Risk for Coronary Heart Disease Changed Among U.S. Adults?. Journal of the American College of Cardiology 48:6, 1177-1182
CrossRef78
Graham Nichol, Riyad Karmy-Jones, Chris Salerno, Lisa Cantore, Lance Becker. (2006) Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation 70:3, 381-394
CrossRef79
Michael P. Fay, Ram C. Tiwari, Eric J. Feuer, Zhaohui Zou. (2006) Estimating Average Annual Percent Change for Disease Rates without Assuming Constant Change. Biometrics 62:3, 847-854
CrossRef80
Roman Fleischhackl, Gerry Foitik, Gerald Czech, Bernhard Roessler, Martina Mittlboeck, Hans Domanovits, Klaus Hoerauf. (2006) Reaching the public via a multi media campaign as a first step to nationwide public access defibrillation. Resuscitation 69:2, 269-275
CrossRef81
Gian Paolo Rossi, Giuseppe Maiolino, Teresa Maria Seccia, Alberto Burlina, Silvia Zavattiero, Maurizio Cesari, Daniele Sticchi, Luigi Pedon, Mario Zanchetta, Achille C Pessina. (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. Journal of Hypertension 24:5, 851-859
CrossRef82
Md. Khalid Pasha, Syed Muzeeb, Shaik Jafar Sadik Basha, Dhanya Shashikumar, Ramesh Mullangi, Nuggehally R. Srinivas. (2006) Analysis of five HMG-CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis andin vitro metabolism studies. Biomedical Chromatography 20:3, 282-293
CrossRef83
Walter C Willett. (2006) The Mediterranean diet: science and practice. Public Health Nutrition 9:1a,
CrossRef84
David B. Reed, Alice Birnbaum, Lawrence H. Brown, Robert E. O'Connor, Jerome L. Fleg, Mary A. Peberdy, Lois Van Ottingham, Alfred P. Hallstrom. (2006) Location of Cardiac Arrests in the Public Access Defibrillation Trial. Prehospital Emergency Care 10:1, 61-67
CrossRef85
Herng-Ching Lin, Chin-Shyan Chen, Hsin-Chien Lee, Tsai-Ching Liu. (2006) Physician and Hospital Characteristics Related to Length of Stay for Acute Myocardial Infarction Patients. Circulation Journal 70:6, 679-685
CrossRef86
Roldano Scognamiglio, Christian Negut, Angelo Ramondo, Antonio Tiengo, Angelo Avogaro. (2006) Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus. Journal of the American College of Cardiology 47:1, 65-71
CrossRef87
Paulo J. Nicola, Cynthia S. Crowson, Hilal Maradit-Kremers, Karla V. Ballman, Véronique L. Roger, Steven J. Jacobsen, Sherine E. Gabriel. (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis & Rheumatism 54:1, 60-67
CrossRef88
Kevin L. Thomas, Eric J. Velazquez. (2005) Therapies to prevent heart failure post-myocardial infarction. Current Heart Failure Reports 2:4, 174-182
CrossRef89
Alejandro Macchia, Giacomo Levantesi, Rosa M. Marfisi, Maria G. Franzosi, Aldo P. Maggioni, Gian L. Nicolosi, Carlo Schweiger, Luigi Tavazzi, Gianni Tognoni, Franco Valagussa, Roberto Marchioli. (2005) Determinantes de insuficiencia cardíaca tardía postinfarto de miocardio: resultados del estudio GISSI Prevenzione. Revista Española de Cardiología 58:11, 1266-1272
CrossRef90
Stanley Watkins, David Thiemann, Josef Coresh, Neil Powe, Aaron R. Folsom, Wayne Rosamond. (2005) Fourteen-Year (1987 to 2000) Trends in the Attack Rates of, Therapy for, and Mortality from Non–ST-Elevation Acute Coronary Syndromes in Four United States Communities. The American Journal of Cardiology 96:10, 1349-1355
CrossRef91
PM Rothwell, AJ Coull, LE Silver, JF Fairhead, MF Giles, CE Lovelock, JNE Redgrave, LM Bull, SJV Welch, FC Cuthbertson, LE Binney, SA Gutnikov, P Anslow, AP Banning, D Mant, Z Mehta. (2005) Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). The Lancet 366:9499, 1773-1783
CrossRef92
Marc Licker, Ewa Mariethoz, Manuel Jorge Costa, Denis Morel. (2005) Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion*. Critical Care Medicine 33:10, 2302-2308
CrossRef93
Chiara Pedone, Arend F. L. Schinkel, Abdou Elhendy, Ron T. Domburg, Roelf Valkema, Elena Biagini, Maarten L. Simoons, Jeroen J. Bax, Don Poldermans. (2005) Incremental prognostic value of dobutamine–atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity. European Journal of Nuclear Medicine and Molecular Imaging 32:9, 1057-1063
CrossRef94
Ruediger R. Noppens, Julia Kofler, Patricia D. Hurn, Richard J. Traystman. (2005) Dose-dependent neuroprotection by 17??-estradiol after cardiac arrest and cardiopulmonary resuscitation. Critical Care Medicine 33:7, 1595-1602
CrossRef95
Robert D Winslow, Davendra Mehta, Valentin Fuster. (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nature Clinical Practice Cardiovascular Medicine 2:7, 352-360
CrossRef96
G. Nichol, P. Steen, J. Herlitz, L.J. Morrison, I. Jacobs, J.P. Ornato, R. O’Connor, V. Nadkarni. (2005) International Resuscitation Network Registry: design, rationale and preliminary results. Resuscitation 65:3, 265-277
CrossRef97
Masoor Kamalesh, Usha Subramanian, Anahita Ariana, Stephen Sawada, William Tierney. (2005) Similar Decline in Post-Myocardial Infarction Mortality among Subjects with and without Diabetes. The American Journal of the Medical Sciences 329:5, 228-233
CrossRef98
Hidehiro Takei, Jack P. Strong, Chikao Yutani, Gray T. Malcom. (2005) Comparison of coronary and aortic atherosclerosis in youth from Japan and the USA. Atherosclerosis 180:1, 171-179
CrossRef99
Raja Varma, Renee Garrick, John McClung, William H. Frishman. (2005) Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease. Cardiology in Review 13:2, 98-107
CrossRef100
Gregory S. Makowski, Melinda L. Ramsby, Gale R. Ramsby. (2005) An indium:calcium phosphate colloid that specifically targets fibrin. Journal of Biomedical Science 12:2, 421-429
CrossRef101
Hilal Maradit-Kremers, Cynthia S. Crowson, Paulo J. Nicola, Karla V. Ballman, V
ronique L. Roger, Steve J. Jacobsen, Sherine E. Gabriel. (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis & Rheumatism 52:2, 402-411
CrossRef102
Victor J. Marder. (2005) The interaction of dietary supplements with antithrombotic agents: Scope of the problem. Thrombosis Research 117:1-2, 7-13
CrossRef103
Andrea Salonia, Alberto Briganti, Piero Montorsi, Tommaso Maga, Federico Deh??, Giuseppe Zanni, Bruno Mazzoccoli, Nazareno Suardi, Patrizio Rigatti, Francesco Montorsi. (2005) Safety and Tolerability of Oral Erectile Dysfunction Treatments in the Elderly. Drugs & Aging 22:4, 323-338
CrossRef104
Tsukasa Ishihara, Hirotoshi Kakuta, Hiroshi Moritani, Tohru Ugawa, Isao Yanagisawa. (2004) Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors. Bioorganic & Medicinal Chemistry 12:22, 5899-5908
CrossRef105
Dario Cattaneo, Sara Baldelli, Simona Merlini, Stefania Zenoni, Norberto Perico, Giuseppe Remuzzi. (2004) Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives. Expert Opinion on Therapeutic Patents 14:11, 1553-1566
CrossRef106
T.Jared Bunch, Roger D. White, Paul A. Friedman, Thomas E. Kottke, Lambert A. Wu, Douglas L. Packer. (2004) Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-year population-based study. Heart Rhythm 1:3, 255-259
CrossRef107
Etta L. Fanning. (2004) Evidence-Based Disease Management: Its Role in Cardiovascular Risk Reduction. Disease Management 7:supplement 1, S-7-S-10
CrossRef108
The Public Access Defibrillation Trial Investigators. (2004) Public-Access Defibrillation and Survival after Out-of-Hospital Cardiac Arrest. New England Journal of Medicine 351:7, 637-646
Full Text109
Teddy Kosoglou, Paul Statkevich, Bo Yang, Ramachandran Suresh, Yali Zhu, Tanya Boutros, Stephen E. Maxwell, Renger Tiessen, David L. Cutler. (2004) Pharmacodynamic interaction between ezetimibe and rosuvastatin. Current Medical Research and Opinion 20:8, 1185-1195
CrossRef110
J. M. Perschbacher, G. S. Reeder, S. J. Jacobsen, S. A. Weston, J. M. Killian, A. Slobodova, V. L. Roger. (2004) Evidence-Based Therapies for Myocardial Infarction: Secular Trends and Determinants of Practice in the Community. Mayo Clinic Proceedings 79:8, 983-991
CrossRef111
G Nichol, E Huszti, J Rokosh, A Dumbrell, J McGowan, L Becker. (2004) Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research?. Resuscitation 62:1, 3-23
CrossRef112
Donna L Armstrong, David Strogatz, Ruby Wang. (2004) United States coronary mortality trends and community services associated with occupational structure, among blacks and whites, 1984–1998. Social Science & Medicine 58:11, 2349-2361
CrossRef113
GRACE LU-YAO, THERESE A. STUKEL, SIU-LONG YAO. (2004) CHANGING PATTERNS IN COMPETING CAUSES OF DEATH IN MEN WITH PROSTATE CANCER: A POPULATION BASED STUDY. The Journal of Urology 171:6, 2285-2290
CrossRef114
Søren Rasmussen, Steen Z Abildstrom, Måns Rosén, Mette Madsen. (2004) Case–fatality rates for myocardial infarction declined in Denmark and Sweden during 1987–1999. Journal of Clinical Epidemiology 57:6, 638-646
CrossRef115
Alissa D. Jacobs, Alice S. Ammerman, Susan T. Ennett, Marci K. Campbell, Katherine W. Tawney, Semra A. Aytur, Stephen W. Marshall, Julie C. Will, Wayne D. Rosamond. (2004) Effects of a Tailored Follow-Up Intervention on Health Behaviors, Beliefs, and Attitudes. Journal of Women's Health 13:5, 557-568
CrossRef116
Kristin L Herron, Ingrid E Lofgren, Matthew Sharman, Jeff S Volek, Maria Luz Fernandez. (2004) High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification. Metabolism 53:6, 823-830
CrossRef117
K. Steenland, S. Hu, J. Walker. (2004) All-Cause and Cause-Specific Mortality by Socioeconomic Status Among Employed Persons in 27 US States, 1984-1997. American Journal of Public Health 94:6, 1037-1042
CrossRef118
Wayne Rosamond. (2004) Are Migraine and Coronary Heart Disease Associated? An Epidemiologic Review. Headache: The Journal of Head and Face Pain 44:s1, S5-S12
CrossRef119
Nancy E. Sherwood, Bettina M. Beech, Lisa M. Klesges, Mary Story, Joel Killen, Tiffany McDonald, Thomas N. Robinson, Charlotte Pratt, Ainong Zhou, Karen Cullen, Janice Baranowski. (2004) Measurement characteristics of weight concern and dieting measures in 8–10-year-old African-American girls from GEMS pilot studies. Preventive Medicine 38, 50-59
CrossRef120
Rigobert Lapu-Bula, Elizabeth Ofili. (2004) Diastolic heart failure: The forgotten manifestation of hypertensive heart disease. Current Hypertension Reports 6:3, 164-170
CrossRef121
J. Fang, M. H. Alderman. (2004) Does Supplemental Private Insurance Affect Care of Medicare Recipients Hospitalized for Myocardial Infarction?. American Journal of Public Health 94:5, 778-782
CrossRef122
S. Khan, A. Kundi, S. Sharieff. (2004) Prevalence of right ventricular myocardial infarction in patients with acute inferior wall myocardial infarction. International Journal of Clinical Practice 58:4, 354-357
CrossRef123
Brian C. Hiestand, Dawn M. Prall, Christopher J. Lindsell, James W. Hoekstra, Charles V. Pollack, Judd E. Hollander, Brian R. Tiffany, W. Frank Peacock, Deborah B. Diercks, W. Brian Gibler. (2004) Insurance Status and the Treatment of Myocardial Infarction at Academic Centers. Academic Emergency Medicine 11:4, 343-348
CrossRef124
Tom Wilsgaard, Egil Arnesen. (2004) Change in serum lipids and body mass index by age, sex, and smoking status: The Tromsø study 1986–1995. Annals of Epidemiology 14:4, 265-273
CrossRef125
Audrey Rosinberg, Tanveer A Khan, Frank W Sellke, Roger J Laham. (2004) Therapeutic angiogenesis for myocardial ischemia. Expert Review of Cardiovascular Therapy 2:2, 271-283
CrossRef126
Michelle W. Krause, Mark Massing, Abhijit Kshirsagar, Wayne Rosamond, Ross J. Simpson. (2004) Combination Therapy Improves Survival After Acute Myocardial Infarction in the Elderly with Chronic Kidney Disease #. Renal Failure 26:6, 715-725
CrossRef127
Tsukasa Ishihara, Hirotoshi Kakuta, Hiroshi Moritani, Tohru Ugawa, Isao Yanagisawa. (2004) Synthesis and Biological Evaluation of Quinuclidine Derivatives Incorporating Phenothiazine Moieties as Squalene Synthase Inhibitors. CHEMICAL & PHARMACEUTICAL BULLETIN 52:10, 1204-1209
CrossRef128
Julia Steinberger. (2003) Diagnosis of the metabolic syndrome in children. Current Opinion in Lipidology 14:6, 555-559
CrossRef129
Nancy E. Sherwood, Mary Story, Dianne Neumark-Sztainer, Sarah Adkins, Marsha Davis. (2003) Development and implementation of a visual card-sorting technique for assessing food and activity preferences and patterns in African American girls. Journal of the American Dietetic Association 103:11, 1473-1479
CrossRef130
Jens Friberg, Pernille Buch, Henrik Scharling, Niels Gadsbøll, Gorm B. Jensen. (2003) Rising Rates of Hospital Admissions for Atrial Fibrillation. Epidemiology 14:6, 666-672
CrossRef131
Charles R Bridges. (2003) Cardiac surgery in African Americans. The Annals of Thoracic Surgery 76:4, S1356-S1362
CrossRef132
Steven J Kernis, Kishore J Harjai, Gregg W Stone, Lorelei L Grines, Judith A Boura, Michael W Yerkey, William O’Neill, Cindy L Grines. (2003) The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology 42:7, 1173-1177
CrossRef133
Gregg C. Fonarow. (2003) In-hospital initiation of statin therapy in patients with acute coronary events. Current Atherosclerosis Reports 5:5, 394-402
CrossRef134
Tsukasa Ishihara, Hirotoshi Kakuta, Hiroshi Moritani, Tohru Ugawa, Shuichi Sakamoto, Shin-ichi Tsukamoto, Isao Yanagisawa. (2003) Syntheses of 3-Ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels. Bioorganic & Medicinal Chemistry 11:17, 3735-3745
CrossRef135
Sıdıka Ertürk, Armağan Önal, Sevil Müge Çetin. (2003) Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples. Journal of Chromatography B 793:2, 193-205
CrossRef136
Kenneth K. Wu. (2003) Soluble thrombomodulin and coronary heart disease. Current Opinion in Lipidology 14:4, 373-375
CrossRef137
Michael Clearfield. (2003) Evolution of Cholesterol Management Therapies: Exploiting Potential for Further Improvement. American Journal of Therapeutics 10:4, 275-281
CrossRef138
Sandra Secchiero, Laura Sciacovelli, Lorena Zardo, Mario Plebani. (2003) Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs. Clinica Chimica Acta 333:2, 221-230
CrossRef139
P. J. Grant. (2003) The genetics of atherothrombotic disorders: a clinician's view. Journal of Thrombosis and Haemostasis 1:7, 1381-1390
CrossRef140
Brandi J Witt, Véronique L Roger. (2003) Sex differences in heart disease incidence and prevalence: implications for intervention. Expert Opinion on Pharmacotherapy 4:5, 675-683
CrossRef141
David R Magnin, Scott A Biller, John Wetterau, Jeffrey A Robl, John K Dickson, Prakash Taunk, Thomas W Harrity, R.Michael Lawrence, C.-Q Sun, Tammy Wang, Janette Logan, Olga Fryszman, Fergal Connolly, Kern Jolibois, Lori Kunselman. (2003) Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents. Bioorganic & Medicinal Chemistry Letters 13:7, 1337-1340
CrossRef142
Claudia Langenberg, Rebecca Hardy, Diana Kuh, Michael EJ Wadsworth. (2003) Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. Journal of Hypertension 21:3, 537-543
CrossRef143
A. Rosengren, D. S. Thelle, M. Koster, M. Rosen. (2003) Changing sex ratio in acute coronary heart disease: data from Swedish national registers 1984-99. Journal of Internal Medicine 253:3, 301-310
CrossRef144
Tanveer A Khan, Frank W Sellke, Roger J Laham. (2003) Therapeutic angiogenesis: protein-based therapy for coronary artery disease. Expert Opinion on Pharmacotherapy 4:2, 219-226
CrossRef145
(2003) The Public Access Defibrillation (PAD) Trial. Resuscitation 56:2, 135-147
CrossRef146
David J. Moliterno, Albert W. Chan. (2003) Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. Journal of the American College of Cardiology 41:4, S49-S54
CrossRef147
Valery L Feigin, Carlene MM Lawes, Derrick A Bennett, Craig S Anderson. (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. The Lancet Neurology 2:1, 43-53
CrossRef148
Mitchell N. Rashid, Francisco Fuentes, Robert C. Touchon, Paulette S. Wehner. (2003) Obesity and the Risk for Cardiovascular Disease. Preventive Cardiology 6:1, 42-47
CrossRef149
Paul A. Landsbergis. (2003) The Changing Organization of Work and the Safety and Health of Working People: A Commentary. Journal of Occupational and Environmental Medicine 45:1, 61-72
CrossRef150
Radovan Hojs, Tanja Hojs-Fabjan, Breda Pečovnik Balon. (2003) Atherosclerosis in Patients with End-Stage Renal Failure Prior to Initiation of Hemodialysis. Renal Failure 25:2, 247-254
CrossRef151
Saibal Kumar Das, V.L. Narasimha Rao Krovvidi, H. Jagadheshan, Javed Iqbal. (2002) Synthetic studies of cis-4-Amino-l-proline derivatives as novel lipid lowering agents. Bioorganic & Medicinal Chemistry Letters 12:24, 3579-3581
CrossRef152
Redfield, Margaret M., . (2002) Heart Failure — An Epidemic of Uncertain Proportions. New England Journal of Medicine 347:18, 1442-1444
Full Text153
Caffrey, Sherry L., Willoughby, Paula J., Pepe, Paul E., Becker, Lance B., . (2002) Public Use of Automated External Defibrillators. New England Journal of Medicine 347:16, 1242-1247
Full Text154
EUAN ASHLEY, JONATHAN MYERS, VICTOR FROELICHER. (2002) Exercise testing scores as an example of better decisions through science. Medicine & Science in Sports & Exercise 34:8, 1391-1398
CrossRef155
Harin Padma-nathan, Ian Eardley, Robert A Kloner, Alan M Laties, Francesco Montorsi. (2002) A 4-year update on the safety of sildenafil citrate (Viagra®). Urology 60:2, 67-90
CrossRef156
Véronique L Roger, Jill Killian, Mary Henkel, Susan A Weston, Tauqir Y Goraya, Barbara P Yawn, Thomas E Kottke, Robert L Frye, Steven J Jacobsen. (2002) Coronary disease surveillance in Olmsted County objectives and methodology. Journal of Clinical Epidemiology 55:6, 593-601
CrossRef157
Susan J. Appel, Joanne S. Harrell, Shibing Deng. (2002) Racial and Socioeconomic Differences in Risk Factors for Cardiovascular Disease Among Southern Rural Women. Nursing Research 51:3, 140-147
CrossRef158
Isao Saito, Hideki Ozawa, Hiroshi Aono, Toshiko Ikebe, Tsuyoshi Yamashita, Yoshihiro Makino. (2002) Trends in fatal coronary heart disease among people aged 25–74 years in Oita City, Japan, from 1987–1998. Journal of Clinical Epidemiology 55:5, 469-476
CrossRef159
Harry B. Burke. (2002) Challenges in Dyslipidemia. Heart Disease 4:3, 141-146
CrossRef160
Hugo Saner, Esther Borner Rodriguez, Andrea Kummer-Bangerter, Reinhart Schüppel, Martin von Planta. (2002) Quality of life in long-term survivors of out-of-hospital cardiac arrest. Resuscitation 53:1, 7-13
CrossRef161
Gregg C. Fonarow. (2002) Statin therapy after acute myocardial infarction: Are we adequately treating high-risk patients?. Current Atherosclerosis Reports 4:2, 99-106
CrossRef162
C. Noel Bairey Merz, James Dwyer, Cheryl K. Nordstrom, Kenneth G. Walton, John W. Salerno, Robert H. Schneider. (2002) Psychosocial Stress and Cardiovascular Disease: Pathophysiological Links. Behavioral Medicine 27:4, 141-147
CrossRef163
Steen Z. Abildstrom, Søren Rasmussen, Mette Madsen. (2002) Significant Decline in Case Fatality after Acute Myocardial Infarction in Denmark--a Population-based Study from 1994 to 2001. Scandinavian Cardiovascular Journal 36:5, 287-291
CrossRef164
Itaru Adachi, Hiroaki Akagi, Hiroaki Shimomura, Tomomi Nakamura, Sadae Miyazaki, Tatsuya Umeda, Yasushi Kitaura, Isamu Narabayashi. (2002) Long-Term Outcome of a Residual Scar From Myocardial Infarction After Coronary Artery Bypass Grafting. Circulation Journal 66:5, 445-445
CrossRef165
Albert W. Chan, David J. Moliterno. (2001) Defining the role of abciximab for acute coronary syndromes: Lessons from CADILLAC, ADMIRAL, GUSTO IV, GUSTO V, and TARGET. Current Opinion in Cardiology 16:6, 375-383
CrossRef166
S.Chiu Wong, Lynn A Sleeper, E.Scott Monrad, Mark A Menegus, Angela Palazzo, Vladimir Dzavik, Alice Jacobs, Xianjiao Jiang, Judith S Hochman. (2001) Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. Journal of the American College of Cardiology 38:5, 1395-1401
CrossRef167
Thomas G. Pickering. (2001) In Praise of Walking: An Antidote to Increasing Health Care Costs in the Elderly?. The Journal of Clinical Hypertension 3:6, 380-382
CrossRef168
Carlos F. Mendes de Leon, Vicki DiLillo, Susan Czajkowski, Jennifer Norten, James Schaefer, Diane Catellier, James A. Blumenthal. (2001) Psychosocial Characteristics After Acute Myocardial Infarction: The ENRICHD Pilot Study. Journal of Cardiopulmonary Rehabilitation 21:6, 353-362
CrossRef169
Caldwell B. Esselstyn. (2001) Resolving the Coronary Artery Disease Epidemic Through Plant-Based Nutrition. Preventive Cardiology 4:4, 171-177
CrossRef170
Simon Capewell, Kate MacIntyre, Simon Stewart, Jim WT Chalmers, James Boyd, Alan Finlayson, Adam Redpath, Jill P Pell, John JV McMurray. (2001) Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study. The Lancet 358:9289, 1213-1217
CrossRef171
E. Barnett, J. Halverson. (2001) Local Increases in Coronary Heart Disease Mortality Among Blacks and Whites in the United States, 1985-1995. American Journal of Public Health 91:9, 1499-1506
CrossRef172
Marc Evans, Penny Owen, Arthur Ogunko. (2001) Therapy and clinical trials. Current Opinion in Lipidology 12:3, 367-369
CrossRef173
John M. Westfall, Joe McGloin. (2001) Impact of Double Counting and Transfer Bias on Estimated Rates and Outcomes of Acute Myocardial Infarction. Medical Care 39:5, 459-468
CrossRef174
P Targonski. (2001) Referral to Autopsy: Effect of Antemortem Cardiovascular Disease A Population-Based Study in Olmsted County, Minnesota. Annals of Epidemiology 11:4, 264-270
CrossRef175
Cheryl K. Nordstrom, Kathleen M. Dwyer, C. Noel Bairey Merz, Anne Shircore, James H. Dwyer. (2001) Work-Related Stress and Early Atherosclerosis. Epidemiology 12:2, 180-185
CrossRef176
Joachim Jankowski, Joost Hagemann, Min-Sung Yoon, Markus Van Der Giet, Nina Stephan, Walter Zidek, Hartmut Schlüter, Martin Tepel. (2001) Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney International 59:3, 1134-1141
CrossRef177
Khalid Barakat, Paul Wilkinson, Abdul Suliman, Kulasegaram Ranjadayalan, Adam Timmis. (2001) Journal of Cardiovascular Risk 8:1, 21-29
CrossRef178
Torbjørn Graven, øystein Krüger, Gunnar Brøn. (2001) Epidemiological Consequences of Introducing New Biochemical Markers for Detection of Acute Myocardial Infarction. Scandinavian Cardiovascular Journal 35:4, 233-237
CrossRef179
Finlay A. McAlister, Raj Padwal. (2001) Implementation of Guidelines for Diagnosing and Treating Hypertension. Disease Management and Health Outcomes 9:7, 361-369
CrossRef180
Sean A Coady, Paul D Sorlie, Lawton S Cooper, Aaron R Folsom, Wayne D Rosamond, David E Conwill. (2001) Validation of death certificate diagnosis for coronary heart disease. Journal of Clinical Epidemiology 54:1, 40-50
CrossRef181
Katerina Shetler, Arna Karlsdottir, Victor Froelicher. (2001) Assessing Patients with Possible Heart Disease Using Scores. Sports Medicine 31:6, 387-408
CrossRef182
Jun Watanabe, Kaoru Iwabuchi, Yoshito Koseki, Mitsumasa Fukuchi, Tsuyoshi Shinozaki, Masahito Miura, Tatsuya Komaru, Yutaka Kagaya, Kunio Shirato, Shigenori Kitaoka, Nobumasa Ishide, Tamotsu Takishima. (2001) Declining Trend in the In-Hospital Case-Fatality Rate From Acute Myocardial Infarction in Miyagi Prefecture From 1980 to 1999. Japanese Circulation Journal 65:11, 941-946
CrossRef183
Walter C. Willett. (2000) Will High-Carbohydrate/Low-Fat Diets Reduce the Risk of Coronary Heart Disease?. Proceedings of the Society for Experimental Biology and Medicine 225:3, 187-190
CrossRef184
Dominic L. Raco. (2000) Changes in classic risk factors for CHD only partly accounted for changes in coronary event rates. Evidence-based Cardiovascular Medicine 4:4, 87-88
CrossRef185
Aidan P. Bolger, Stefan D. Anker. (2000) Tumour Necrosis Factor in Chronic Heart Failure. Drugs 60:6, 1245-1257
CrossRef186
G. Russell Warnick, Ishwarlal Jialal, MD, PhD, Martin H. Kroll, MD, Nader Rifai, PhD, Thomas G. Cole, PhD, Gerald Cooper, MD, PhD. (2000) Standardization of Lipoprotein Reporting. American Journal of Clinical Pathology 114:5, 696-702
CrossRef187
V. A. Freedman, L. G. Martin. (2000) Contribution of chronic conditions to aggregate changes in old-age functioning. American Journal of Public Health 90:11, 1755-1760
CrossRef188
T E Kottke, M J Brekke, L N Brekke, L C Dale, C L Brandel, S W DeBoer, S N Hayes, R S Hoffman, P A Menzel, T T Nguyen, R J Thomas. (2000) The CardioVision 2020 baseline community report card.. Mayo Clinic Proceedings 75:11, 1153-1159
CrossRef189
Jussi Mikkelsson, Markus Perola, Pekka Laippala, Antti Penttilä, Pekka J. Karhunen. (2000) Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac death. Journal of the American College of Cardiology 36:4, 1317-1323
CrossRef190
Wayne D. Rosamond, Alice S. Ammerman, Joseph L. Holliday, Kathy W. Tawney, Kelly J. Hunt, Thomas C. Keyserling, Julie C. Will, Ali H. Mokdad. (2000) Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project. Preventive Medicine 31:4, 370-379
CrossRef191
Hu, Frank B., Stampfer, Meir J., Manson, JoAnn E., Grodstein, Francine, Colditz, Graham A., Speizer, Frank E., Willett, Walter C., . (2000) Trends in the Incidence of Coronary Heart Disease and Changes in Diet and Lifestyle in Women. New England Journal of Medicine 343:8, 530-537
Full Text192
Elizabeth Barnett, Joel A Halverson, Gregory A Elmes, Valerie E Braham. (2000) Metropolitan and Non-Metropolitan Trends in Coronary Heart Disease Mortality within Appalachia, 1980–1997. Annals of Epidemiology 10:6, 370-379
CrossRef193
Ernest T. Hawk, Scott M. Lippman. (2000) PRIMARY CANCER PREVENTION TRIALS. Hematology/Oncology Clinics of North America 14:4, 809-830
CrossRef194
Gan, Sandra C., Beaver, Shelli K., Houck, Peter M., MacLehose, Richard F., Lawson, Herschel W., Chan, Leighton, . (2000) Treatment of Acute Myocardial Infarction and 30-Day Mortality among Women and Men. New England Journal of Medicine 343:1, 8-15
Full Text195
TAUQIR Y. GORAYA, STEVEN J. JACOBSEN, PAUL G. BELAU, SUSAN A. WESTON, THOMAS E. KOTTKE, VÉRONIQUE L. ROGER. (2000) Validation of Death Certificate Diagnosis of Out-of-Hospital Coronary Heart Disease Deaths in Olmsted County, Minnesota. Mayo Clinic Proceedings 75:7, 681-687
CrossRef196
T Y Goraya, S J Jacobsen, P G Belau, S A Weston, T E Kottke, V L Roger. (2000) Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota.. Mayo Clinic Proceedings 75:7, 681-687
CrossRef197
Ernest Hawk, Jaye L. Viner, Julia A. Lawrence. (2000) Biomarkers as surrogates for cancer development. Current Oncology Reports 2:3, 242-250
CrossRef198
Manohara P.J Senaratne, Gis Smith, Sajad S Gulamhusein. (2000) Feasibility and safety of early exercise testing using the Bruce protocol after acute myocardial infarction. Journal of the American College of Cardiology 35:5, 1212-1220
CrossRef199
Donald D. Hensrud. (2000) Clinical Preventive Medicine in Primary Care: Background and Practice: 1. Rationale and Current Preventive Practices. Mayo Clinic Proceedings 75:2, 165-172
CrossRef200
D D Hensrud. (2000) Clinical preventive medicine in primary care: background and practice: 1. Rationale and current preventive practices.. Mayo Clinic Proceedings 75:2, 165-172
CrossRef201
Gunnar Erikssen, Knut Liestøl, Jørg. (2000) Hypothesis: The Recent Decline in Coronary Heart Disease Mortality - Mainly a Shift From Fatal to Non-fatal Events?. Scandinavian Cardiovascular Journal 34:5, 468-474
CrossRef202
B TAVERNIER, R SANCHEZ, F PATTOU, J MALLAT, M SPERANDIO, C PROYE. (2000) Mortalité postopératoire dans un service universitaire de chirurgie générale : incidence des décès d'origine cardiaque. Annales Françaises d’Anesthésie et de Réanimation 19:1, 54-61
CrossRef203
Janice E Williams, Mark Massing, Wayne D Rosamond, Paul D Sorlie, Herman A Tyroler. (1999) Racial Disparities in CHD Mortality from 1968–1992 in the State Economic Areas Surrounding the ARIC Study Communities. Annals of Epidemiology 9:8, 472-480
CrossRef204
M. Plebani, M. Zaninotto. (1999) Cardiac Markers: Centralized or Decentralized Testing?. Clinical Chemistry and Laboratory Medicine 37:11-12, 1113-1117
CrossRef205
Martin J Kendall, Sarah L Nuttall. (1999) Anti-oxidant therapy for the treatment of coronary artery disease. Expert Opinion on Investigational Drugs 8:11, 1763-1784
CrossRef206
T Kottke. (1999) Counseling: implementing our knowledge in a hurried and complex world. American Journal of Preventive Medicine 17:4, 295-298
CrossRef207
Williamson, David F., . (1999) The Prevention of Obesity. New England Journal of Medicine 341:15, 1140-1141
Full Text208
Frank B. Hu, Meir J. Stampfer. (1999) Nut consumption and risk of coronary heart disease: A review of epidemiologic evidence. Current Atherosclerosis Reports 1:3, 204-209
CrossRef209
Russell V. Luepker. (1999) Decreased CHD mortality, case fatality and recurrent MI rates in the USA. Evidence-based Cardiovascular Medicine 3:3, 83-84
CrossRef210
F Alamgir, JL Caplin, JGF Cleland, M Norell, GC Kaye. (1999) Survival trends, coronary event rates, and the MONICA project. The Lancet 354:9181, 863
CrossRef211
Wayne D Rosamond, Lloyd E Chambless, Aaron R Folsom. (1999) Survival trends, coronary event rates, and the MONICA project. The Lancet 354:9181, 864
CrossRef212
Donald E Fry. (1999) Surgical infections in 2050: I predict. Current Surgery 56:7-8, 389-392
CrossRef213
Wood, Alastair J.J., , Knopp, Robert H., . (1999) Drug Treatment of Lipid Disorders. New England Journal of Medicine 341:7, 498-511
Full Text214
Annette J Dobson, Patrick McElduff, Richard Heller, Hilary Alexander, Paula Colley, Kate D'Este. (1999) Changing Patterns of Coronary Heart Disease in the Hunter Region of New South Wales, Australia. Journal of Clinical Epidemiology 52:8, 761-771
CrossRef215
Roya Behbahani, Catherine Verme-Gibboney, Angela M. Romanelli. (1999) Chlamydia pneumoniae and anti-infective therapy: Their role in the pathogenesis and treatment of coronary artery disease. Clinical Therapeutics 21:8, 1286-1300
CrossRef216
V L Roger, S J Jacobsen, S A Weston, K R Bailey, T E Kottke, R L Frye. (1999) Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994.. Mayo Clinic Proceedings 74:7, 651-657
CrossRef217
Joseph E Prince, Christie M Ballantyne. (1999) Adhesion molecules in cardiovascular disease. Expert Opinion on Therapeutic Targets 3:2, 263-277
CrossRef218
M. Plebani, M. Zaninotto. (1999) Cardiac markers: present and future. International Journal of Clinical & Laboratory Research 29:2, 56-63
CrossRef219
Kate L. Lapane, Marilyn M. Barbour, Anne Van Haaren, Giovanni Gambassi. (1999) Antiischemic Therapy in Patients with Coronary Heart Disease Living in Long-term Care. Pharmacotherapy 19:5, 627-634
CrossRef220
Veikko Salomaa, Carmen Matei, Nena Aleksic, Leticia Sansores-Garcia, Aaron R Folsom, Harinder Juneja, Lloyd E Chambless, Kenneth K Wu. (1999) Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atheroscierosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. The Lancet 353:9166, 1729-1734
CrossRef221
Robert M. Brenner, Elizabeth M. Wrone. (1999) The epidemic of cardiovascular disease in end-stage renal disease. Current Opinion in Nephrology and Hypertension 8:3, 365-369
CrossRef222
Joseph S Alpert. (1999) Coronary heart disease: where have we been and where are we going?. The Lancet 353:9164, 1540-1541
CrossRef223
A.P. Simopoulos. (1999) Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins, Leukotrienes and Essential Fatty Acids 60:5-6, 421-429
CrossRef224
Hugh Tunstall-Pedoe, Kari Kuulasmaa, Markku Mähönen, Hanna Tolonen, Esa Ruokokoski. (1999) Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. The Lancet 353:9164, 1547-1557
CrossRef225
Mosterd, Arend, D'Agostino, Ralph B., Silbershatz, Halit, Sytkowski, Pamela A., Kannel, William B., Grobbee, Diederick E., Levy, Daniel, . (1999) Trends in the Prevalence of Hypertension, Antihypertensive Therapy, and Left Ventricular Hypertrophy from 1950 to 1989. New England Journal of Medicine 340:16, 1221-1227
Full Text226
(1999) Rates of Death from Coronary Heart Disease. New England Journal of Medicine 340:9, 730-732
Full Text227
Peter W. F. Wilson. (1999) Metabolic risk factors for coronary heart disease: current and future prospects. Current Opinion in Cardiology 14:2, 176
CrossRef228
Levy, Daniel, , Thom, Thomas J.. (1998) Death Rates from Coronary Disease — Progress and a Puzzling Paradox. New England Journal of Medicine 339:13, 915-917
Full Text
